Video

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Hear from Certara experts on how Certara IQ modernizes QSP modeling with AI, collaboration tools,…

Certara2025 年 10 月 16 日

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

Certara2025 年 10 月 15 日

Conference

ICAComP 2025

Certara2025 年 10 月 8 日

Guide

MBMA vs. Meta-Analysis: Quick Comparison Guide

Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…

Certara2025 年 10 月 8 日

Conference

Dutch Medicines Days

Certara2025 年 10 月 7 日

White Paper

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Replace or waive TQT studies with validated C-QT analysis strategies accepted by FDA, EMA, PMDA.…

Certara2025 年 10 月 3 日

Case Study

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

Certara2025 年 10 月 2 日

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara2025 年 9 月 22 日

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…

Certara2025 年 9 月 17 日

Guide

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…

Certara2025 年 9 月 11 日

模型引导的药物开发

Inside Certara IQ™: Building the Future of QSP with Josh Apgar & Chris Bouton

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

ICAComP 2025

MBMA vs. Meta-Analysis: Quick Comparison Guide

Dutch Medicines Days

C-QTc and C-QT Analysis: Replacing TQT Studies and Accelerating Cardiovascular Safety Decisions

Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

订阅时事通讯

快捷链接

解决方案

联系我们